Filing Details
- Accession Number:
- 0001209191-17-065973
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-15 16:47:00
- Reporting Period:
- 2017-12-13
- Accepted Time:
- 2017-12-15 16:47:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1278710 | Robert Coffman | C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-13 | 7,500 | $5.40 | 13,808 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-12-13 | 7,500 | $18.90 | 6,308 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-13 | 7,500 | $0.00 | 7,500 | $5.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-03-09 | No | 4 | M | Direct |
Footnotes
- Includes 1,561 shares obtained upon the vesting of an RSU on February 5, 2015
- Option is fully-vested and exercisable